Market Price

24.65 

0.00 0.0%

as of Nov 28 '22

52 Week Range:

17.55 34.68


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors. It also offers InSight Denials to analyze, track, trend, and report on denial data; Trisus Healthcare Intelligence, a solution that provides insights into resource consumption on the patient level; Trisus Medication Analytic solutions; and Trisus supplies assistant solutions. In addition, the company provides Sentinel, a drug tracking solution; Sentrex, a SaaS-based solution that helps covered entities expand medication access; Sentrex 330; Referral Verification System; and Sentry Core, a solution that simplifies the complexities of pharmacy procurement, utilization, and compliances. Further, it offers appeal and professional services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22
Equity (BVPS) 1.42
1.66
2.37
2.11
2.48
2.20
growth rate 8.1% 12.6% -11.0% 17.5% -11.3%
Earnings BIT 11.27
12.57
14.41
16.50
18.59
19.24
19.21
19.73
20.24
growth rate 11.5% 14.7% 14.5% 12.7% 3.5% -0.2% 2.7% 2.6%
Avg.PE 28.77
2.50
79.42
40.69
40.69
40.69
31.40
growth rate -91.3% 3,076.8% -48.8% 0.0% 0.0% -22.8%
ROA 15.04
13.25
12.55
12.43
12.30
14.17
16.11
14.60
15.16
6.04
growth rate -11.9% -5.3% -1.0% -1.1% 15.2% 13.7% -9.4% 3.8% -60.2%
ROE 25.47
21.07
19.97
20.29
21.06
24.12
28.46
26.88
26.26
7.85
growth rate -17.3% -5.2% 1.6% 3.8% 14.5% 18.0% -5.6% -2.3% -70.1%
ROIC 25.22
20.86
19.85
20.15
20.89
23.75
28.10
26.42
24.97
7.78
growth rate -17.3% -4.8% 1.5% 3.7% 13.7% 18.3% -6.0% -5.5% -68.8%
Cur. Ratio 1.78
1.99
2.08
1.91
1.70
1.81
1.38
1.43
1.52
5.16
growth rate 11.8% 4.5% -8.2% -11.0% 6.5% -23.8% 3.6% 6.3% 239.5%
Quick Ratio 1.56
1.97
2.05
1.88
1.67
1.77
1.33
1.38
1.47
5.11
growth rate 26.3% 4.1% -8.3% -11.2% 6.0% -24.9% 3.8% 6.5% 247.6%
Leverage 1.63
1.56
1.62
1.64
1.78
1.64
1.92
1.78
1.69
1.20
growth rate -4.3% 3.9% 1.2% 8.5% -7.9% 17.1% -7.3% -5.1% -29.0%
Balance Sheet Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22
Acct.Receivable 9.00
16.67
11.98
18.00
13.56
10.60
16.87
18.95
15.35
35.29
growth rate 85.3% -28.2% 50.3% -24.7% -21.8% 59.1% 12.4% -19.0% 130.0%
Acct.Payable 2.00
1.23
1.34
1.47
0.76
0.82
1.71
0.72
1.84
3.59
growth rate -38.6% 9.2% 9.8% -48.5% 8.6% 107.3% -57.9% 156.5% 94.5%
Cur.Assets 46.00
53.67
56.84
69.77
68.55
65.34
66.40
68.85
255.05
88.41
growth rate 16.7% 5.9% 22.7% -1.7% -4.7% 1.6% 3.7% 270.4% -65.3%
Total Assets 64.00
72.86
78.22
93.78
97.15
98.93
106.30
115.76
311.60
568.80
growth rate 13.8% 7.4% 19.9% 3.6% 1.8% 7.5% 8.9% 169.2% 82.5%
Cash 30.00
32.61
41.83
48.81
53.17
52.83
47.61
47.85
235.62
47.16
growth rate 8.7% 28.3% 16.7% 8.9% -0.6% -9.9% 0.5% 392.4% -80.0%
Cur.Liabilities 23.00
25.86
29.77
40.97
37.80
47.29
46.47
45.35
49.41
82.51
growth rate 12.5% 15.1% 37.6% -7.7% 25.1% -1.7% -2.4% 9.0% 67.0%
Liabilities 23.00
27.94
30.59
40.97
37.80
47.29
46.47
47.36
51.32
235.77
growth rate 21.5% 9.5% 33.9% -7.8% 25.1% -1.7% 1.9% 8.4% 359.4%
LT Debt 103.59
growth rate
Equity 44.92
47.63
52.81
59.36
51.65
59.84
68.40
260.28
333.02
growth rate 6.0% 10.9% 12.4% -13.0% 15.9% 14.3% 280.6% 28.0%
Common Shares 27.00
27.00
27.00
27.00
27.00
28.00
0.53
0.54
0.54
0.62
0.66
growth rate 0.0% 0.0% 0.0% 0.0% 3.7% -98.1% 0.2% 0.2% 16.4% 5.6%
Cash Flow Statement Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22
Capital Expenditures 0.31
0.38
0.42
0.65
0.43
0.65
0.19
0.16
0.35
growth rate 22.7% 10.6% 56.5% -33.6% 50.7% -71.4% -15.0% 122.0%
Cash Dividends 5.36
5.39
5.95
6.36
7.82
8.50
9.08
9.70
12.98
growth rate 0.5% 10.5% 6.8% 23.0% 8.7% 6.8% 6.9% 33.8%
Cash From OA 7.00
8.11
19.58
15.42
17.85
29.99
13.46
20.47
23.54
26.96
growth rate 15.8% 141.5% -21.2% 15.8% 68.0% -55.1% 52.0% 15.0% 14.6%
FCF per Share 0.35
0.55
0.52
0.46
0.55
0.64
growth rate 25.4% -1.9% -11.5% 19.6% 16.4%
Sale Purchase of Stock 0.04
0.04
0.10
0.52
growth rate 0.0% 137.5% 451.6%
FCF 9.00
6.00
8.00
18.00
13.00
13.00
25.00
3.00
11.00
13.00
26.61
growth rate -33.3% 33.3% 125.0% -27.8% 0.0% 92.3% -88.0% 266.7% 18.2% 104.7%
Income Statement Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22
Sales 41.00
42.57
44.82
49.85
57.80
67.07
71.40
71.49
75.58
165.54
growth rate 3.8% 5.3% 11.2% 16.0% 16.0% 6.5% 0.1% 5.7% 119.0%
Op.Income 8.00
11.27
12.57
14.41
16.50
18.59
19.24
19.21
19.73
20.24
growth rate 40.9% 11.5% 14.7% 14.5% 12.7% 3.5% -0.2% 2.7% 2.6%
IBT 11.29
12.50
13.92
16.88
18.93
18.32
19.30
13.17
13.10
growth rate 10.7% 11.4% 21.3% 12.1% -3.2% 5.4% -31.8% -0.5%
Net Income 8.00
8.61
9.39
10.58
13.53
15.80
14.99
16.84
12.91
9.41
growth rate 7.6% 9.0% 12.6% 27.9% 16.8% -5.1% 12.4% -23.4% -27.1%
EPS 0.33
0.30
0.32
0.34
0.39
0.49
0.57
0.55
0.61
0.47
growth rate -9.1% 6.7% 6.3% 14.7% 25.6% 16.3% -3.5% 10.9% -23.0%
Gross Profit 39.00
40.63
42.40
46.84
54.21
63.66
67.01
66.97
70.21
142.37
growth rate 4.2% 4.3% 10.5% 15.8% 17.4% 5.3% -0.1% 4.8% 102.8%
R&D 6.98
6.99
7.67
9.11
13.17
10.41
12.27
growth rate 0.1% 9.8% 18.8% 44.6% -21.0% 17.9%

Quarterly Statements

Item Name Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Earnings BIT 4.88
3.83
3.83
6.29
6.29
growth rate -21.4% 0.0% 64.1% 0.0%
Balance Sheet Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Acct.Receivable 15.35
64.91
64.91
35.29
35.29
growth rate 323.0% 0.0% -45.6% 0.0%
Acct.Payable 1.84
5.55
5.55
3.59
3.59
growth rate 200.7% 0.0% -35.3% 0.0%
Cur.Assets 255.05
119.38
119.38
88.41
88.41
growth rate -53.2% 0.0% -26.0% 0.0%
Total Assets 311.60
609.32
609.32
568.80
568.80
growth rate 95.6% 0.0% -6.7% 0.0%
Cash 235.62
41.70
41.70
47.16
47.16
growth rate -82.3% 0.0% 13.1% 0.0%
Cur.Liabilities 49.41
119.65
119.65
82.51
82.51
growth rate 142.2% 0.0% -31.0% 0.0%
Liabilities 51.32
275.06
275.06
235.77
235.77
growth rate 436.0% 0.0% -14.3% 0.0%
LT Debt 107.08
107.08
103.59
103.59
growth rate 0.0% -3.3% 0.0%
Equity 260.28
334.27
334.27
333.02
333.02
growth rate 28.4% 0.0% -0.4% 0.0%
Common Shares 0.62
0.66
0.66
0.66
0.66
growth rate 5.5% 0.0% 0.2% 0.0%
Cash Flow Statement Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Capital Expenditures 0.03
0.12
0.12
0.05
0.05
growth rate 352.7% 0.0% -58.2% 0.0%
Cash Dividends 2.19
3.61
3.61
2.87
2.87
growth rate 65.3% 0.0% -20.5% 0.0%
Cash From OA 5.12
5.04
5.04
8.44
8.44
growth rate -1.6% 0.0% 67.5% 0.0%
Sale Purchase of Stock
growth rate
FCF 5.09
4.92
4.92
8.39
8.39
growth rate -3.5% 0.0% 70.6% 0.0%
Income Statement Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Sales 18.78
40.09
40.09
42.68
42.68
growth rate 113.4% 0.0% 6.5% 0.0%
Op.Income 4.88
3.83
3.83
6.29
6.29
growth rate -21.4% 0.0% 64.1% 0.0%
IBT 1.62
3.12
3.12
3.43
3.43
growth rate 92.7% 0.0% 10.2% 0.0%
Net Income 2.23
2.36
2.36
2.34
2.34
growth rate 5.9% 0.0% -0.7% 0.0%
Gross Profit 17.64
35.17
35.17
36.02
36.02
growth rate 99.4% 0.0% 2.4% 0.0%
R&D
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (72.94)

YOY Growth Grade:

C (60.69)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 38.70 38.70
EPS / Growth 0.64

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 50.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 40.0% 50.0% 52.9%
Future PE 0.01 25.80 48.14
Future EPS 18.43 36.73 44.34
Value Price
MOS %
0.05
-99.8%
234.29
850.5%
527.58
2,040.3%
MOS Price 0.02 117.14 263.79
IRT 7.36 6.44 6.24

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.